In the last few years, the concept of myocardial infarction with non-obstructive coronary artery disease (MINOCA) has been one of the emerging hot topics in the field of cardiovascular medicine. The most recent studies in this field, focused on multiple approaches including invasive and noninvasive imaging techniques or various laboratory biomarkers, did not succeed to completely elucidate this frequent cause of acute myocardial infarction (AMI). The consensus papers published by the working groups of the European Society of Cardiology (ESC) have established the diagnostic criteria for MINOCA, defined as the absence of stenosis higher than 50% in an epicardial coronary artery at coronary angiography, in the clinical context of an AMI. At the same time, the Fourth Universal Definition of Myocardial Infarction, published in 2018, acknowledges this condition as a separate entity. 1,2 emerging evidence Currently, there is a lack of randomized, controlled studies on MINOCA as a separate clinical entity. However, a large number of retrospective, registry-based studies have been published recently, which highlight the importance of this entity, as it represents approximately 5-15% of all AMIs. 3 Furthermore, MINOCA cannot be considered a benign condition, as the large SWEDEHEART registry-based study, which randomized 9,136 MINOCA patients with a mean follow-up period of 4 years, reported all-cause mortality rates as high as 13.5% in MINOCA patients, of which almost 50% were declared as of cardiovascular cause. The investigators also reported important major adverse car-diovascular event (MACE) rates in MINOCA patients, with recurrent myocardial infarction in 7%, ischemic stroke in 4%, and hospitalization for heart failure in 6.4% of this group. 4 At the same time, MINOCA patients with recurrent infarction had a 22% mortality rate at the 2-year follow-up. 4 A recent large registry published by Dreyer et al., which included an impressive number of 16,849 MINOCA patients older than 65 years, reported a 25% MACE rate at the 1-year follow-up, with lower mortality and heart failure rates compared to patients with obstructive coronary artery disease (CAD). 5 Nevertheless, other recent studies suggested similar one-year survival and MACE rates as in patients with obstructive AMI. 6-8 The clinical and demographic characteristics of MINOCA patients are highly heterogeneous, although systematic reviews reported younger age, high proportion of female gender (around 50%), black race, Hispanic ethnicity, and lower prevalence of classical risk factors for CAD such as dyslipidemia, diabetes, hypertension, smoking, or family history of AMI. 3 importance of functional testing and modern imaging techniques As there are extensive pathophysiological mechanisms involved in the development of MINOCA, it should be considered a working diagnosis until the identification of the underlying cause. The exclusion of non-ischemic causes that might lead to similar clinical, electrocardiographic aspects or elevated cardiac enzymes (e.g., myocarditis, pulmonary embolism, sepsis) is key for the formulation of a correct final diagnosis. This involves the use of modern imaging techniques, as well as functional assessment.
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